CTVA Chart

1 Month

	Date	Diff
	2025-04-21	-1.04 %
Corteva (CTVA) stock fell by 1.04% as part of a broader trend impacting agriculture stocks, which are reacting to economic changes and global demand fluctuations.
	2025-04-17	+0.91 %
Corteva, Inc. (CTVA) stock rose by 0.91% last night, driven by positive movements among institutional investors adjusting their holdings, analysts issuing mostly favorable ratings, and a general optimism surrounding its agricultural business performance. Corteva, Inc. (CTVA) stock rose by 0.91% following positive Q1 2025 earnings estimates and an "Overweight" rating with a target price boost to $71.00 from KeyCorp, indicating analysts' optimism and investor confidence in the company's future performance. Corteva (CTVA) stock rose by 0.91% following positive earnings per share estimates for FY2026 from KeyCorp, which projected earnings of $3.47 per share and maintained an "Overweight" rating with a price target of $71.00, indicating investor confidence in the company’s future performance.
	2025-04-16	-0.84 %
Corteva (CTVA) stock experienced a 0.84% decline, despite an increase in its target price by KeyCorp, likely due to mixed earnings reports and insider selling that raised investor concerns.
	2025-04-15	-0.98 %
Corteva (CTVA) stock declined by 0.98% due to a downgrade in the U.S. chemicals sector by Bank of America, which highlighted weakening global trade and cyclical demand as key challenges impacting the sector.
	2025-04-10	-1.06 %
Corteva (CTVA) stock experienced a decline of -1.06% following Wellington Management Group LLP's significant reduction of its stake in the company by 47% in the last quarter, which raised concerns among investors about potential institutional selling.
	2025-04-09	+5.48 %
Corteva (CTVA) stock rose by 5.48%, reaching $56.28, as it was among the top agriculture stocks to watch due to its significant trading volume and the broader positive sentiment in the agriculture sector. Corteva (CTVA) stock rose 5.48% recently, likely due to positive sentiment surrounding the agriculture sector and its performance compared to other leading farmland stocks.
	2025-04-02	+0.71 %
Corteva (CTVA) stock rose 0.71% following an upgrade by Argus from a "hold" to a "buy" rating, which included a price target increase to $69, suggesting potential upside and positive investor sentiment.
	2025-03-24	+0.57 %
Corteva (CTVA) stock increased by 0.57% following a report of several institutional investors, including Harbour Investments Inc., raising their stakes in the company, which may indicate growing confidence in Corteva's financial outlook.
	2025-03-21	-0.18 %
Corteva, Inc. (CTVA) stock recently fell by 0.18% despite a generally positive outlook from analysts, who have given it a "Moderate Buy" rating, primarily due to poor earnings results that missed consensus estimates and insider selling of shares, which raised concerns among investors.
	2025-03-18
Corteva, Inc. (CTVA) stock remained unchanged at 0.0% down as of last night, following a series of institutional investments and analyst upgrades, despite posting lower-than-expected quarterly earnings. The stock's lack of movement may be attributed to mixed market sentiment and a disappointing earnings report that revealed the company missed analysts' earnings expectations.
	2025-03-13	-0.69 %
Corteva (CTVA) stock fell by 0.69% due to a broader analysis by Goldman Sachs indicating the agricultural market is stabilizing after peak highs from the Russia-Ukraine war, with expected normalization later this year despite a favorable outlook for Spring 2025.
	2025-03-10	-0.53 %
Corteva (CTVA) stock declined by 0.53% amid concerns surrounding Bayer's potential withdrawal of its Roundup weedkiller from the U.S. market due to ongoing product liability litigation, which raises uncertainties in the agriculture sector and affects competitive dynamics.
	2025-02-27	+0.03 %
Corteva, Inc. (CTVA) experienced a slight increase in its stock price, attributed to positive sentiment following institutional investment activities, a share buyback program indicating perceived undervaluation, dividend announcements, and analysts upgrading the stock's ratings.
	2025-02-24	-0.24 %
Corteva, Inc. (NYSE:CTVA) stock declined by 0.24% despite receiving an average recommendation of "Moderate Buy" from analysts, likely due to its recent earnings report which showed it missed earnings estimates, contributing to investor concerns.
	2025-02-20	+0.3 %
The article discusses Corteva, Inc. (CTVA) stock, noting a recent increase of 0.3% partly due to institutional investors, including Allworth Financial LP increasing their stakes, and analysts raising their price targets, indicating positive market sentiment. Corteva's stock likely went up as a result of increased institutional investment and favorable analyst ratings which suggest potential for growth. Corteva, Inc. (CTVA) stock experienced a slight increase of 0.3% driven by significant institutional investment, including a new position by Strategic Financial Concepts LLC and increased stakes from other large investors, as well as positive analyst ratings and price target increases reflecting confidence in the company’s future performance. Corteva, Inc. (CTVA) saw a 0.3% increase in its stock price, attributed to various institutional investment movements, including a share buyback plan indicating confidence in its valuation, and positive adjustments in price targets from multiple analysts.
	2025-02-19	-1.27 %
Corteva (CTVA) stock experienced a decline of 1.27% due to its overall performance being tracked alongside other notable agriculture stocks, potentially influenced by market factors affecting the agriculture industry, such as commodity prices and global demand.
	2025-02-14	+1.75 %
Corteva (CTVA) stock rose 1.75% following increased institutional investment, positive price target upgrades from multiple analysts, and the announcement of a share buyback plan, indicating strong confidence in the company's value.
	2025-02-13	+1.29 %
Corteva (CTVA) stock rose by 1.29% due to positive analyst upgrades regarding its price targets and ratings, coupled with institutional investment activity and a share repurchase plan indicating that the company believes its stock is undervalued.
	2025-02-10	-0.21 %
Corteva (CTVA) stock decreased by 0.21% despite an increase in its price target by Royal Bank of Canada, primarily due to the company's recent earnings report that missed consensus estimates, with reported earnings per share of $0.32 compared to an expected $0.34.
	2025-02-07	-0.03 %
Corteva (CTVA) stock decreased by 0.03% following abrdn plc's reduction of its holdings in the company by 15.2%, a trend that may signal decreased institutional confidence, compounded by weaker earnings results that fell short of analyst expectations.
	2025-02-04	+1.69 %
Corteva, Inc. (CTVA) stock rose by 1.69% partly due to significant institutional investments, including a notable increase in holdings by Caprock Group LLC, and positive analyst ratings that highlight its growth potential and a recent stock buyback program suggesting the company views its stock as undervalued.
	2025-02-03	-1.01 %
Corteva (CTVA) stock dropped by -1.01% as investors await the company's quarterly earnings report, which analysts expect to reveal earnings of $0.34 per share and revenue of $4.01 billion, suggesting cautious sentiment ahead of the announcement. The article discusses Corteva's (CTVA) recent stock decline of -1.01% and broader concerns regarding the influence of technological monopolies on agriculture and society as a whole. The contraction of Corteva's stock is attributed to ongoing worries about the monopolistic practices in the agriculture sector and the implications of algorithmic and data-driven control exerted by large corporations.
	2025-01-30	+1.77 %
Corteva, Inc. (CTVA) shares rose by 1.77% due to a consensus recommendation of "Moderate Buy" from analysts and recent institutional investments, along with positive sentiment from a stock repurchase plan indicating management's belief that the stock is undervalued. Corteva, Inc. (CTVA) shares rose 1.77% to reach a new 52-week high following Citigroup's upgrade, raising its price target from $69.00 to $74.00 and maintaining a buy rating on the stock. This increase is attributed to positive analyst ratings and upgrades, indicating investor confidence in Corteva's performance.
	2025-01-29	+1.12 %
Corteva (CTVA) stock rose by 1.12% as a result of positive developments in the North America trifluralin market, highlighted by increased production and usage of trifluralin in agricultural practices, which enhances demand for herbicides and signifies the company's strong position in the market.
	2025-01-24	-0.36 %
Corteva, Inc. (CTVA) shares declined by 0.36% as several institutional investors adjusted their positions, amidst mixed analyst ratings and pricing targets, indicating market fluctuations and possibly concerns over stock valuation.
	2025-01-23	+2.69 %
Corteva, Inc. (CTVA) stock rose 2.69% as institutional investors increased their holdings in the company, signifying confidence in its valuation, particularly following the authorization of a $3 billion share buyback plan which suggests the company's leadership believes its shares are undervalued.
	2025-01-22	-0.97 %
Corteva (CTVA) stock fell by 0.97% despite Barclays raising its price objective from $62.00 to $64.00, likely due to mixed sentiment reflected in other analysts' ratings and potential market adjustments. Corteva, Inc. (CTVA) stock experienced a decline of 0.97%, partially attributed to Wealthcare Advisory Partners LLC reducing its position by 16.1% and various institutional investors adjusting their holdings amidst a fluctuating market environment.
	2025-01-14	+1.6 %
Corteva (CTVA) stock rose by 1.6% due to positive modifications in institutional investor holdings and a share buyback plan indicating confidence in the company's value.
	2025-01-13	+4.97 %
Corteva, Inc. (CTVA) stock rose 4.97% following significant institutional purchases, including Graypoint LLC's new stake, a stock buyback announcement indicating shares may be undervalued, and positive adjustments to price targets by multiple brokerages. Corteva (CTVA) stock rose by 4.97% amid multiple price target adjustments and positive ratings from research firms, while the company announced a share buyback program, signaling confidence in its stock valuation. Corteva (CTVA) stock rose by 4.97% amidst various price target adjustments and favorable ratings from analysts, indicating positive market sentiment and confidence in the company's valuation following announcements such as a stock buyback plan. The stock increase is primarily attributed to analysts maintaining or raising their ratings and price targets, signaling optimism about Corteva's value and potential growth, as well as the announcement of a significant stock repurchase plan, which suggests that company leadership believes the shares are undervalued.
	2024-12-19	-0.44 %
Corteva (CTVA) stock decreased by 0.44% last night, potentially due to negative market sentiment or external factors affecting the agriculture sector, as the article contrasts Corteva with other companies without providing specific reasons for its decline.
	2024-12-09	+0.42 %
Corteva, Inc. (CTVA) stock rose by 0.42% following significant increases in institutional investments, including a 64.9% increase in holdings by Benjamin Edwards Inc., and the announcement of a $3 billion share repurchase program, indicating confidence in the stock's value. Corteva, Inc. (CTVA) experienced a 0.42% increase in its stock price, attributed to factors such as ongoing institutional investment, favorable analyst ratings, and the recently authorized $3 billion stock repurchase program which signals that the board views the stock as undervalued.
	2024-12-06	-2.12 %
Corteva, Inc. (CTVA) stock fell by 2.12% recently, despite increased holdings from several institutional investors, possibly due to market fluctuations and the perception of its stock valuation following a stock buyback announcement and ongoing research analysts' evaluations.
	2024-12-02	-0.02 %
Corteva (CTVA) stock experienced a slight decline of 0.02% amidst ongoing institutional investment activity, with significant recent increases in stakes from several hedge funds and analysts maintaining mostly positive ratings on the stock. The decline may be attributed to typical market fluctuations or investor reactions despite the strong interest from institutional investors, rather than any specific negative news about the company.
	2024-11-21	+3.4 %
The article discusses concerns regarding the contamination of drinking water with PFAS ("forever chemicals") and notes that Corteva (CTVA) stock rose 3.4% amid the worry that a potential Trump reelection could undo progress made in regulating these substances; the stock may have increased due to speculation that companies involved in PFAS litigation, like Corteva, could benefit from future settlements or regulatory changes. Corteva (CTVA) stock rose 3.4% due to the announcement of a $3 billion stock buyback program, signaling the company's belief that its shares are undervalued, along with a recent quarterly dividend declaration which added to investor confidence. Corteva (CTVA) stock rose by 3.4% following a series of bullish actions from institutional investors, a positive outlook from analysts with raised price targets, and the announcement of a $3 billion share buyback plan signaling management's belief in the stock's undervaluation. Corteva (CTVA) stock rose 3.4% following the announcement of a $3.00 billion share buyback program, which signals management's belief that the stock is undervalued.
	2024-11-18	+3.22 %
Corteva, Inc. (CTVA) stock rose 3.22% likely due to increasing interest from institutional investors and analysts, who have issued mostly positive ratings and price targets for the company, despite a senator recently selling shares.
	2024-11-15	-3.83 %
Corteva's (CTVA) stock declined by 3.83% due to a mix of hedge fund activity, analyst rating adjustments, and potential market reactions to its recent financial disclosures, including a lowered price target from JPMorgan Chase.
	2024-11-13	+0.93 %
Corteva, Inc. (NYSE: CTVA) shares saw a 0.93% increase due to a consensus "Moderate Buy" rating from analysts, with a majority recommending buy positions and several raising their price targets.
	2024-11-11	+0.33 %
Corteva (CTVA) stock rose 0.33% following an increase in its price target from UBS Group, which raised it from $67.00 to $71.00 while maintaining a buy rating, signaling positive sentiment among analysts regarding the company's growth potential.
	2024-11-08	-0.53 %
Corteva, Inc. (CTVA) stock experienced a 0.53% decline following disappointing earnings results that missed consensus estimates, along with lower revenue than anticipated.
	2024-11-07	-5.02 %
Corteva, Inc. (CTVA) stock fell by 5.02% following a 1.9% reduction in stake by Stephens Inc. AR in the third quarter, amidst mixed actions from other institutional investors regarding their positions in the company.
	2024-11-06	-0.02 %
Corteva (CTVA) stock was down 0.02% last night, likely impacted by overall market sentiment affected by the strengthening US dollar and foreign fund outflows due to Donald Trump's election victory, which created volatility in the markets. Corteva (CTVA) stock experienced a slight decline of 0.02% amidst broader market fluctuations influenced by the strength of the US dollar and anticipated Federal Reserve interest rate cuts. The drop in Corteva's stock is likely linked to negative market sentiment driven by external economic factors, including foreign fund outflows and geopolitical influences.